| Entry |
|
|---|
| Name |
Resminostat (INN) |
|---|
| Formula |
C16H19N3O4S
|
|---|
| Exact mass |
349.1096
|
|---|
| Mol weight |
349.41
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG03133 Histone deacetylase inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Histone deacetylase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XH Histone deacetylase (HDAC) inhibitors
L01XH07 Resminostat
D13021 Resminostat (INN)
Drug groups [BR:br08330]
Antineoplastic
DG03133 Histone deacetylase inhibitor
D13021 Resminostat
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Histone deacetylase
HDAC
D13021 Resminostat (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 24
1 C8x C 10.1500 -28.0000
2 C8y C 10.1500 -29.4000
3 C8x C 11.3400 -30.1000
4 C8x C 12.6000 -29.4000
5 C8y C 12.6000 -28.0000
6 C8x C 11.3400 -27.3000
7 S4a S 13.7900 -27.3000
8 N4y N 14.9800 -28.0000
9 O3c O 13.0900 -26.1100
10 O3c O 14.4900 -26.1100
11 C8x C 15.4700 -29.3300
12 C8y C 16.8700 -29.3300
13 C8x C 17.2900 -28.0000
14 C8x C 16.1700 -27.1600
15 C1b C 8.9600 -30.1000
16 N1c N 7.7700 -29.4000
17 C1a C 6.5800 -30.1000
18 C1a C 7.7700 -28.0000
19 C2b C 18.0600 -30.0300
20 C2b C 19.2500 -29.3300
21 C5a C 20.4400 -30.0300
22 N1b N 21.6300 -29.3300
23 O5a O 20.4400 -31.4300
24 O1b O 22.8200 -30.0300
BOND 25
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 7 9 2
10 7 10 2
11 8 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 8 14 1
16 2 15 1
17 15 16 1
18 16 17 1
19 16 18 1
20 12 19 1
21 19 20 2
22 20 21 1
23 21 22 1
24 21 23 2
25 22 24 1
|
|---|
